Abstract Submission is Open!
Share your most recent discoveries at this go-to event for professionals in the biosafety and biological threats community.
Oct. 21, 2019, 5 p.m. ET
What You Need Before You Submit Your Abstract
- Abstract Title: Please use a short and concise title that indicates the content of the abstract. (Note: the title is not included in the total character count of 2200).
- Abstract Body Text: Your abstract may have up to 2200 characters, which does not include title, authors, groups, and affiliations. Tables and graphics (maximum of 500 characters) are included in the character count. Spaces are not counted. Do NOT include abstract title, authors or keywords in abstract text. Abstract text may be submitted using either of the following methods: Copy/paste, direct entry keystrokes, or file upload. Your abstract may be written without the use of the following bolded headers (Background, Methods, Results, Conclusion). However, follow the abstract guidelines to ensure all required information about your study is provided in your abstract.
- Author(s) Information: Author(s)'s name(s), institution(s), location(s), title(s).
- Presentation Preference: You will have the opportunity to select a presentation preference of either poster only or poster and oral. If you select poster and oral, you will be required to indicate the oral presentation options that are of interest to you.
If you need technical support and have any questions regarding use of the abstract submission site, please contact technical support at: email@example.com or 217-398-1792.
Additional Submission Information
All abstracts submitted for consideration will be reviewed by at least one member of the Program Committee. The committee will determine if the abstract merits inclusion in the program and, if accepted, will schedule the abstract in the appropriate session for the meeting. An abstract may be rejected for one or more of the following reasons. All decisions relating to acceptance or rejection are final.
- No Background or Hypothesis - The abstract does not clearly indicate the reason for conducting the research or the question being tested by the experiments performed.
- Inadequate Experimental Methods - The investigators failed to describe procedures used or neglected to include important or essential controls.
- Insufficient Data Presented - The investigators failed to show the outcome(s) of their research. Insufficient data are presented to support the authors' conclusion(s).
- No Summary Form of Essential Results - The investigators failed to concisely summarize the result(s) of their research.
- No Conclusion - The investigators failed to describe the conclusions of their research with regard to the hypothesis being tested.
- Duplicate Abstract - The abstract contents substantively overlap with contents of another submitted abstract by the same author or co-author. Reviewers may elect to accept a single abstract and suggest that the authors consolidate their material.
- Not appropriate for the Biothreats meeting - The content of the abstract is not relevant to the defined goals of the Biothreats meeting.
- Promotional in Nature - The abstract was written to promote a specific product or procedure on behalf of a specific company or organization.
- Poorly Written - Improper use of the English language renders the abstract incomprehensible.
- Duplicate Presenting Author - An author can be the presenting author on only one abstract.
Abstract disposition notices will be made available via email notification to presenting authors only the week of Nov. 7, 2019. It is the responsibility of the presenting author to inform all co-authors of disposition status and accepted abstract scheduling information. If you have not received notification by Nov. 14, 2019, please email firstname.lastname@example.org to have a disposition notice resent.
Withdrawals and Penalties
If an abstract must be withdrawn, the author must send a letter of explanation to ASM at email@example.com. If an accepted abstract is published prior to 2020 ASM Biothreats the authors agree to withdraw the abstract. Withdrawals of abstracts made after Nov. 21, 2019, can be subject to a penalty as described below.
Persons who submit abstracts should consider them official communication to the conference. The following cases can incur a penalty, prohibiting the author from presenting papers at ASM meetings and conferences for up to three years. A letter will be mailed to individuals being subject to this penalty. Those who wish to dispute the penalty must write a letter to the Biothreats Program Committee and send it to the attention of the Biothreats Program Assistant at firstname.lastname@example.org. A response letter will be sent to the presenting author once the committee has considered and acted on your exception request.
Students and early career scientists who submit an abstract are eligible to request a Biothreats Travel Award.
Travel awardees are selected by the Biothreats Program Committee on the basis of the scientific quality of the submitted abstracts. Funding from this award is meant only to defray costs for the meeting; abstract submitters may need to obtain additional funding from other sources.
Deadline: Oct. 21, 2019, 5 p.m. ET